Source: ROLL CALL, 11/18/19


When President Donald Trump’s nominee to lead the Food and Drug Administration appears for the first time before a Senate panel on Wednesday, he’ll likely face tough questions about some policy issues that he may not have thought much about previously. While the nominee, Stephen Hahn, is a highly regarded cancer doctor who has helped lead a research hospital with a budget nearly the size of the FDA’s, the confirmation hearing will be a reminder of the breadth of the agency’s work.

For more of this story, click here.